Skip to main content

Advertisement

Table 3 HCV/HIV status among participants at the Miami IDEA syringe exchange

From: Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange

Characteristics Sample total n (%) Fixed site n (%) Mobile van unit n (%) p value
Total 718 (100.0) 591 (82.3) 127 (17.7)  
Prior HCV status
 Negative 340 (54.2) 304 (56.1) 36 (42.9) 0.040
 Positive 266 (42.4) 222 (41.0) 44 (52.4)
 Unknown 21 (3.3) 16 (3.0) 5 (5.9)
HCV test result
 Positive 69 (28.5) 59 (27.6) 10 (35.7) 0.370
 Negative 173 (71.5) 155 (72.4) 18 (64.3)
Prior HIV status
 Negative 584 (88.1) 516 (88.7) 68 (83.95) 0.412
 Positive 70 (10.6) 58 (10.0) 12 (14.81)
 Unknown 9 (1.4) 8 (1.4) 1 (1.23)
HIV test result
 Positive 2 (0.6) 2 (0.70) 0 (0.0) 0.608
 Negative 344 (99.4) 304 (99.4) 40 (100.0)
Currently in HIV treatment, if HIV positive
 Yes 48 (82.8) 39 (83.0) 9 (81.8) 0.927
 No 10 (17.2) 8 (17.0) 2 (18.2)